Agios Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Agios Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Agios Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Agios Pharmaceuticals by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $76M | 1.7M | 44.43 |
2024-06-30 | $77M | 1.8M | 43.12 |
2024-03-31 | $72M | 2.5M | 29.22 |
2023-12-31 | $57M | 2.5M | 22.27 |
2023-09-30 | $61M | 2.5M | 24.75 |
2023-06-30 | $71M | 2.5M | 28.32 |
2023-03-31 | $31M | 1.1M | 26.96 |
2022-12-31 | $33M | 1.2M | 28.08 |
2022-06-30 | $31M | 1.4M | 22.17 |
2022-03-31 | $95M | 3.3M | 29.00 |
2021-12-31 | $102M | 3.1M | 32.87 |
2021-03-31 | $174M | 3.4M | 51.64 |
2020-12-31 | $91M | 2.1M | 43.33 |
2020-09-30 | $54M | 1.6M | 33.33 |
2020-06-30 | $85M | 1.6M | 53.48 |
2020-03-31 | $47M | 1.3M | 35.49 |
2019-12-31 | $45M | 953k | 47.62 |
2019-09-30 | $25M | 758k | 32.43 |
2019-06-30 | $37M | 753k | 49.64 |
2019-03-31 | $67M | 995k | 67.44 |
2018-12-31 | $41M | 895k | 46.11 |
2018-09-30 | $130k | 1.7k | 76.43 |
2018-06-30 | $146k | 1.7k | 85.71 |
2018-03-31 | $114k | 1.4k | 82.01 |
2017-12-31 | $89k | 1.6k | 57.05 |
2017-06-30 | $138k | 2.7k | 51.80 |
2017-03-31 | $878k | 15k | 58.46 |
2016-12-31 | $627k | 15k | 40.87 |
2016-09-30 | $4.0M | 77k | 51.77 |
2016-06-30 | $1.3M | 31k | 42.55 |
2016-03-31 | $168k | 5.9k | 28.57 |
2015-12-31 | $412k | 6.4k | 64.89 |
2015-09-30 | $2.8M | 39k | 70.60 |
2015-06-30 | $18M | 162k | 111.30 |
2015-03-31 | $19M | 202k | 94.26 |
2014-12-31 | $21M | 190k | 111.96 |
2014-09-30 | $8.8M | 143k | 61.34 |
2014-06-30 | $6.6M | 144k | 45.88 |
2014-03-31 | $6.1M | 156k | 39.17 |
2013-12-31 | $774k | 32k | 24.00 |
2013-09-30 | $859k | 31k | 28.00 |